is sublingual tirzepatide as effective as injection GLP-1 for Weight Loss: or Sublingual Tirzepatide for Weight Loss

Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial

Foundayo (orforglipron), a flexible oral GLP-1 option, and Zepbound (tirzepatide), providing dual hormone action for enhanced weight loss, are also available

Contrave is indicated in patients with a BMI of 30 or higher, or 27-30 with at least one weight-related health condition

Overall, after 68 weeks, 83% of adults taking Wegovy lost 5% or more of their weight compared to 31% of adults taking a placebo

For the first 3 to 4 weeks, youll only be able sit with the help of a soft pillow or donut

It is the pivotal molecule in keeping us healthy thanks to its powerful antioxidant elements